These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 33480803)

  • 1. Developing and Optimizing Innovative Tools to Address Familial Hypercholesterolemia Underdiagnosis: Identification Methods, Patient Activation, and Cascade Testing for Familial Hypercholesterolemia.
    Campbell-Salome G; Jones LK; Masnick MF; Walton NA; Ahmed CD; Buchanan AH; Brangan A; Esplin ED; Kann DG; Ladd IG; Kelly MA; Kindt I; Kirchner HL; McGowan MP; McMinn MN; Morales A; Myers KD; Oetjens MT; Rahm AK; Schmidlen TJ; Sheldon A; Simmons E; Snir M; Strande NT; Walters NL; Wilemon K; Williams MS; Gidding SS; Sturm AC
    Circ Genom Precis Med; 2021 Feb; 14(1):e003120. PubMed ID: 33480803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel.
    Sturm AC; Knowles JW; Gidding SS; Ahmad ZS; Ahmed CD; Ballantyne CM; Baum SJ; Bourbon M; Carrié A; Cuchel M; de Ferranti SD; Defesche JC; Freiberger T; Hershberger RE; Hovingh GK; Karayan L; Kastelein JJP; Kindt I; Lane SR; Leigh SE; Linton MF; Mata P; Neal WA; Nordestgaard BG; Santos RD; Harada-Shiba M; Sijbrands EJ; Stitziel NO; Yamashita S; Wilemon KA; Ledbetter DH; Rader DJ;
    J Am Coll Cardiol; 2018 Aug; 72(6):662-680. PubMed ID: 30071997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel LDLR disease-causing variant using capture-based next-generation sequencing screening of familial hypercholesterolemia patients in Taiwan.
    Hsiung YC; Lin PC; Chen CS; Tung YC; Yang WS; Chen PL; Su TC
    Atherosclerosis; 2018 Oct; 277():440-447. PubMed ID: 30270083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving the Detection of Potential Cases of Familial Hypercholesterolemia: Could Machine Learning Be Part of the Solution?
    Stevens CAT; Vallejo-Vaz AJ; Chora JR; Barkas F; Brandts J; Mahani A; Abar L; Sharabiani MTA; Ray KK
    J Am Heart Assoc; 2024 Jun; 13(12):e034434. PubMed ID: 38879446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-utility analysis of searching electronic health records and cascade testing to identify and diagnose familial hypercholesterolaemia in England and Wales.
    Crosland P; Maconachie R; Buckner S; McGuire H; Humphries SE; Qureshi N
    Atherosclerosis; 2018 Aug; 275():80-87. PubMed ID: 29879685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced identification of familial hypercholesterolemia using central laboratory algorithms.
    Ibrahim S; Nurmohamed NS; Nierman MC; de Goeij JN; Zuurbier L; van Rooij J; Schonck WAM; de Vries J; Hovingh GK; Reeskamp LF; Stroes ESG
    Atherosclerosis; 2024 Jun; 393():117548. PubMed ID: 38643673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetically Confirmed Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome.
    Amor-Salamanca A; Castillo S; Gonzalez-Vioque E; Dominguez F; Quintana L; Lluís-Ganella C; Escudier JM; Ortega J; Lara-Pezzi E; Alonso-Pulpon L; Garcia-Pavia P
    J Am Coll Cardiol; 2017 Oct; 70(14):1732-1740. PubMed ID: 28958330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Algorithm for detection and screening of familial hypercholesterolemia in Lithuanian population.
    Aliosaitiene U; Petrulioniene Z; Rinkuniene E; Mainelis A; Brazdziuniene E; Smailyte U; Sileikiene V; Laucevicius A
    Lipids Health Dis; 2024 May; 23(1):136. PubMed ID: 38715054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detecting familial hypercholesterolemia earlier in life by actively searching for affected children:The DECOPIN project.
    Ibarretxe D; Rodríguez-Borjabad C; Feliu A; Bilbao JÁ; Masana L; Plana N
    Atherosclerosis; 2018 Nov; 278():210-216. PubMed ID: 30312929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study.
    Pirillo A; Garlaschelli K; Arca M; Averna M; Bertolini S; Calandra S; Tarugi P; Catapano AL;
    Atheroscler Suppl; 2017 Oct; 29():17-24. PubMed ID: 28965616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of mutations of familial hypercholesterolemia in the 22 Arab countries.
    Alhababi D; Zayed H
    Atherosclerosis; 2018 Dec; 279():62-72. PubMed ID: 30415195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic testing of familial hypercholesterolemia in a real clinical setting.
    Vohnout B; Gabcova D; Huckova M; Klimes I; Gasperikova D; Raslova K
    Wien Klin Wochenschr; 2016 Dec; 128(23-24):916-921. PubMed ID: 27542166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic diagnosis of familial hypercholesterolaemia using a rapid biochip array assay for 40 common LDLR, APOB and PCSK9 mutations.
    Martin R; Latten M; Hart P; Murray H; Bailie DA; Crockard M; Lamont J; Fitzgerald P; Graham CA
    Atherosclerosis; 2016 Nov; 254():8-13. PubMed ID: 27680772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of familial hypercholesterolemia-associated genes on the phenotype of premature myocardial infarction.
    Lee C; Cui Y; Song J; Li S; Zhang F; Wu M; Li L; Hu D; Chen H
    Lipids Health Dis; 2019 Apr; 18(1):95. PubMed ID: 30971288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shortcomings on genetic testing of Familial hypercholesterolemia (FH) in India: Can we collaborate to establish Indian FH registry?
    Reddy LL; Shah SAV; Ashavaid TF
    Indian Heart J; 2022; 74(1):1-6. PubMed ID: 34875256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of clinical diagnostic criteria for familial hypercholesterolemia genetic testing in Poland.
    Mickiewicz A; Chmara M; Futema M; Fijalkowski M; Chlebus K; Galaska R; Bandurski T; Pajkowski M; Zuk M; Wasag B; Limon J; Rynkiewicz A; Gruchala M
    Atherosclerosis; 2016 Jun; 249():52-8. PubMed ID: 27062410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Family cascade screening for equitable identification of familial hypercholesterolemia: study protocol for a hybrid effectiveness-implementation type III randomized controlled trial.
    Johnson C; Chen J; McGowan MP; Tricou E; Card M; Pettit AR; Klaiman T; Rader DJ; Volpp KG; Beidas RS
    Implement Sci; 2024 Apr; 19(1):30. PubMed ID: 38594685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of publicly available LDLR, APOB, and PCSK9 variants associated with familial hypercholesterolemia: application of ACMG guidelines and implications for familial hypercholesterolemia diagnosis.
    Chora JR; Medeiros AM; Alves AC; Bourbon M
    Genet Med; 2018 Jun; 20(6):591-598. PubMed ID: 29261184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recall by genotype and cascade screening for familial hypercholesterolemia in a population-based biobank from Estonia.
    Alver M; Palover M; Saar A; Läll K; Zekavat SM; Tõnisson N; Leitsalu L; Reigo A; Nikopensius T; Ainla T; Kals M; Mägi R; Gabriel SB; Eha J; Lander ES; Irs A; Philippakis A; Marandi T; Natarajan P; Metspalu A; Kathiresan S; Esko T
    Genet Med; 2019 May; 21(5):1173-1180. PubMed ID: 30270359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive Modeling and Structure Analysis of Genetic Variants in Familial Hypercholesterolemia: Implications for Diagnosis and Protein Interaction Studies.
    Larrea-Sebal A; Jebari-Benslaiman S; Galicia-Garcia U; Jose-Urteaga AS; Uribe KB; Benito-Vicente A; Martín C
    Curr Atheroscler Rep; 2023 Nov; 25(11):839-859. PubMed ID: 37847331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.